Other languages Merck & Co., Inc. London S.E.

Equities

Real-time Estimate Tradegate Other stock markets 09:44:04 2024-07-17 am EDT			5-day change	1st Jan Change
114.9 ^EUR	0.00%		+2.60%	0.00%

03:32pm	TD Cowen Adjusts Price Target on Merck to $140 From $135	MT
Jul. 16	Merck: to present its advances in HIV at AIDS 24	CF

Merck : présentera ses avancées sur le VIH au congrès AIDS 24	Jul. 16
Novo owner backs Swiss biotech Asceneuron in $100 million round	Jul. 16
Sector Update: Health Care Stocks Mixed Premarket Friday	Jul. 12
Sector Update: Health Care	Jul. 12
Merck : finalise l'acquisition de EyeBio	Jul. 12
Merck Completes Eyebiotech Acquisition	Jul. 12
Immutep Achieves 'Positive' Results From Cohort B of Phase 2B Cancer Trial; Shares Rise Pre-Bell	Jul. 12
Merck & Co., Inc. completed the acquisition of Eyebiotech Limited.	Jul. 11
ETF de la semana: Consumo discrecional como tema a jugar	Jul. 09
Merck : achète la branche aquatique de Elanco Animal Health	Jul. 09
Merck's Animal Health Division Completes $1.3 Billion Acquisition of Elanco Animal Health's Aqua Business	Jul. 09
Prelude Therapeutics Inks Deal With Merck for Phase 2 Study to Evaluate its SMARCA2 Degrader With Keytruda	Jul. 09
ETF de la semana: Invertir en Europa fuera de Francia para evitar el riesgo político	Jul. 04
Stocks to watch as Biden and Trump vie for presidency	Jul. 03
MÄRKTE USA/Freundlich - Kräftige Gewinne bei Autoaktien	Jul. 02
MÄRKTE USA/Seitwärts in ruhigem Handel - Tesla auf Sechsmonatshoch	Jul. 02
MÄRKTE USA/Freundlich - Technologieaktien favorisiert	Jul. 01
MÄRKTE USA/Etwas fester - Marktzinsen steigen weiter	Jul. 01
Merck, Orion Convert Ongoing Collaboration Into Exclusive Global License for Opevesostat	Jul. 01
Merck : accord de licence avec Orion Corp. pour opevesostat	Jul. 01

No results for this search